Federal Court Creates New MDL for Ozempic and Other GLP-1 Drugs Linked to Vision Loss (NAION) December 17, 2025 Federal Court Creates New MDL for Ozempic and Other GLP-1 Drugs Linked to Vision Loss (NAION) The U.S. Judicial Panel on Multidistrict Litigation has ordered the creation of a new federal multidistrict litigation consolidating lawsuits alleging that popular GLP-1 receptor agonist drugs caused patients to suffer serious vision injuries, including non-arteritic anterior ischemic optic neuropathy, […] Read More
New Study Links Depo-Provera to Higher Risk of Brain Tumor October 6, 2025 A new study published in JAMA Neurology in September 2025 found that women in the United States who use the birth control shot Depo-Provera (depot medroxyprogesterone acetate, or DMPA) may face a higher risk of developing meningioma, a type of brain tumor that forms in the membranes surrounding the brain and spinal cord. Key Findings […] Read More
Do You Have a Depo-Provera Case? Understanding Your Rights After a Meningioma Diagnosis September 2, 2025 Depo-Provera Lawsuit News Read More